1. Home
  2. POWI vs DNTH Comparison

POWI vs DNTH Comparison

Compare POWI & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Power Integrations Inc.

POWI

Power Integrations Inc.

HOLD

Current Price

$47.88

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

HOLD

Current Price

$48.26

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POWI
DNTH
Founded
1988
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
POWI
DNTH
Price
$47.88
$48.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
10
Target Price
$61.00
$70.22
AVG Volume (30 Days)
906.3K
941.0K
Earning Date
02-05-2026
03-10-2026
Dividend Yield
1.86%
N/A
EPS Growth
N/A
N/A
EPS
0.32
N/A
Revenue
$445,550,000.00
$3,078,000.00
Revenue This Year
$7.93
N/A
Revenue Next Year
$7.60
N/A
P/E Ratio
$142.32
N/A
Revenue Growth
10.49
N/A
52 Week Low
$30.86
$13.37
52 Week High
$68.20
$57.50

Technical Indicators

Market Signals
Indicator
POWI
DNTH
Relative Strength Index (RSI) 69.34 53.21
Support Level $44.22 $48.86
Resistance Level $48.57 $54.85
Average True Range (ATR) 1.87 3.27
MACD 0.09 0.13
Stochastic Oscillator 87.63 39.56

Price Performance

Historical Comparison
POWI
DNTH

About POWI Power Integrations Inc.

Power Integrations Inc designs, develops, and markets analog and mixed-signal integrated circuits (ICs) and other electronic components and circuitry used in high-voltage power conversion. Products are used in power converters that convert electricity from a high-voltage source to the type of power required for a specified downstream use. Products are used in electronic products including mobile phones, computing and networking equipment, appliances, electronic utility meters, battery-powered tools, industrial controls, home automation, or Internet of Things applications such as networked thermostats, power strips, and security devices. Geographically, the company generates maximum revenue from China and Hong Kong.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

Share on Social Networks: